Physicists Fear Civil War

Particle physicists battle solid-state physicists over slice of a shrinking pie BALTIMORE--Inside the gleaming vaults of the Baltimore Convention Center last month, 1,900 researchers were giving 1,200 talks, seminars, and press conferences, all part of the usually festive spring meeting of the American Physical Society. But in the corridors, much of the talk was anything but festive. The APS is torn by a bitter internal squabble pitting the society’s largest constituency, 9,000 solid-s

Written byCharles Mann
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Particle physicists battle solid-state physicists over slice of a shrinking pie

BALTIMORE--Inside the gleaming vaults of the Baltimore Convention Center last month, 1,900 researchers were giving 1,200 talks, seminars, and press conferences, all part of the usually festive spring meeting of the American Physical Society. But in the corridors, much of the talk was anything but festive. The APS is torn by a bitter internal squabble pitting the society’s largest constituency, 9,000 solid-state physicists, against its smaller but better-known group of 4,700 high-energy physicists. Reduced to its most basic level, this is a battle between advocates of Big and Little Science, or, given the actual size of the funding requests involved, between Big and Not-So-Big Science. It comes in the era of the Great Deficit, so money is tight. Condensed-matter physicists want a big infusion of funds to explore high-temperature superconductors. Particle physicists want to build the super-conducting supercollider, a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies